Table 5 Comparison of characteristics between survivals and deaths
| Â | Survivors(n = 39) | Deaths (n = 7) | p value |
|---|---|---|---|
Age | 62 (22, 85) | 68 (55, 78) | 0.668 |
Gender | Â | Â | Â |
Male | 30 (76.9) | 6 (85.7) | 1.000 |
Female | 9 (23.1) | 1 (14.3) | Â |
Underlying disease | Â | Â | Â |
   Viral hepatitis | 13 (33.3) | 5 (71.4) | 0.093 |
   Liver cirrhosis | 4 (10.2) | 4 (57.1)* | 0.012 |
   Chronic liver dysfunction | 13 (33.3) | 6 (85.7)* | 0.015 |
   Diabetes mellitus | 16 (41.0) | 2 (28.6) | 0.688 |
   Chronic renal failure | 5 (12.8) | 4 (57.1)* | 0.020 |
Immunocompromised(DM, liver dysfunction, CRF, malignancy) | 27 (69.2) | 7 (100) | 0.165 |
Pathogens | Â | Â | Â |
   Gram positive pathogen | 10 (25.6) | 1 (14.3) | 0.667 |
   Gram negative pathogen | 29 (74.4) | 6 (85.7) |  |
Involved region | Â | Â | Â |
   Upper extremity | 11 (28.2) | 4 (57.1) | 0.193 |
   Lower extremity | 28 (71.8) | 3 (42.9) |  |
Shock at ER | 19 (48.7) | 6 (85.7) | 0.106 |